Program Project: GENE MUTATION AND RESCUE IN HUMAN DIAPHRAGMATIC HERNIA

计划项目:人类膈疝的基因突变与挽救

基本信息

  • 批准号:
    8079810
  • 负责人:
  • 金额:
    $ 158.49万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-07-01 至 2016-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): In the quest to unravel the etiology of Congenital Diaphragmatic Hernia (CDH), a prevalent (1:2500 live births) high impact (50% mortality with high morbidity) birth defect with phenotypic and genetic complexity, we are combining novel and traditional investigative strategies to one of the largest cohort of human patients with CDH. Collectively, we are employing molecular genetic, molecular cytogenetic, genomic, developmental, bioinformatic, and stem cell strategies along with the use of multiple model organisms. The strategies that we employ can serve as a template for identifying genes in pathways responsible not only for CDH, but for additional congenital anomalies, as well. The foundation of our work is the Infrastructure developed for ascertaining and recruiting almost all patients with CDH from two academic tertiary pediatric surgical centers, Massachusetts General Hospital (MGH) and Children's Hospital Boston (CHB), each offering state of the art medical, surgical, and genetic diagnosis, and management. Patients and families with CDH are interviewed comprehensively by study staff and carefully phenotyped by a senior geneticist; biological samples are obtained using sensitive protocols adapted for infants and children from each proband and from as many family members as possible, and are banked for proposed iterative genetic studies. Gene candidates are selected for sequencing when there is convergence from multiple lines of inquiry [i.e., copy number variations (CNVs) detected on array Comparative Genomic Hybridization (aCGH) or Single Nucleotide Polymorphism (SNP) arrays, genes in shared intervals detected on linkage analysis in affected belonging to multiplex CDH families, expressed genes in the developing primordial diaphragm, and bioinformatic algorithms that prioritize multiple candidate variants detected by the aforementioned platforms and from annotation of animal models with diaphragm defects]. The functional significance of the most promising candidates is subsequently assessed in multiple animal models. The evolution of available sequencing capabilities to lower costs opens the door to examine the multiple genes or polygeneity that we now know will contribute to a birth defect phenotype such as CDH. Given the national and International outreach and reputation of our genetic partnerships and the strength of the voluntary support network provided by the exceptional parents of patients with CDH, the study has extended beyond our two institutions to ascertain a number of seminal multiplex kindreds, including both consanguineous and non-consanguineous families, from the U.S. and internationally. RELEVANCE: The overarching goal of this study is to converge the multiple genes detected by these complementary approaches into cogent molecular pathways that will reveal polygeneic defects in the pathways and point toward potential treatment paradigms to prevent or alleviate this mortal or morbid congenital anomaly. Further, the methods devised for this study of CDH may have broader implications across other congenital anomalies.
描述(由申请人提供):为了揭示先天性diaphragmatic疝气的病因(CDH),这是一种普遍的(1:2500 Live Births)高影响力(50%死亡率具有高发病率),具有表型和遗传复杂性,我们将小说和传统的研究策略与CODHORT CDH的一员结合起来,将其结合在一起。总体而言,我们使用分子遗传,分子细胞遗传学,基因组,发育,生物信息学和干细胞策略以及使用多种模型生物。我们采用的策略可以用作模板,以识别不仅负责CDH的途径中的基因,而且还可以识别其他先天性异常。 我们工作的基础是用于确定和招募来自两个学术三级儿科手术中心,马萨诸塞州综合医院(MGH)和波士顿儿童医院(CHB)的基础设施,几乎所有CDH患者,每个患者均提供最先进的医学,外科手术,外科手术,遗传诊断和管理。患者和CDH的患者接受研究人员的全面采访,并由高级遗传学家仔细表现出来。使用适合于每个概率的婴儿和儿童以及来自尽可能多的家庭成员的敏感方案获得生物样品,并进行了依靠的迭代遗传研究。当从多种探究线[即,在阵列比较基因组杂交(ACGH)或单核苷酸多态性(SNP)阵列(SNP)阵列中检测到的多种拷贝数变化(CNV)时,选择基因候选物进行测序。 开发原始diaphragm和生物信息学算法,以优先考虑多个候选变体 通过上述平台检测到来自具有隔膜缺陷的动物模型的注释]。随后在多个动物模型中评估了最有前途的候选人的功能意义。 可用的测序能力降低成本的演变为检查多元基因或多元政府的大门打开了我们现在所知道的多元基因或多光学性,这将有助于诸如CDH之类的先天缺陷表型。 鉴于我们的遗传伙伴关系的国家和国际宣传以及CDH患者杰出父母提供的自愿支持网络的实力,该研究已超越了我们的两个机构,以确定许多开创性的多元型物品,包括来自美国和美国国际上的cangunance乱和非传统家庭。 相关性:这项研究的总体目标是将这些互补方法检测到的多个基因汇聚为可结合的分子途径,这些途径将揭示途径中的多元缺陷,并指向潜在的治疗范式,以预防或减轻这种致命或病态的先天性异常。此外,为这项CDH研究设计的方法可能在其他先天性异常中具有更广泛的含义。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

PATRICIA K DONAHOE的其他基金

Administrative Core
行政核心
  • 批准号:
    10159738
    10159738
  • 财政年份:
    2011
  • 资助金额:
    $ 158.49万
    $ 158.49万
  • 项目类别:
ADMINISTRATIVE CORE
行政核心
  • 批准号:
    8143193
    8143193
  • 财政年份:
    2011
  • 资助金额:
    $ 158.49万
    $ 158.49万
  • 项目类别:
PROJECT II: VARIANTS FROM COMPLEMENTARY GENOMIC TECHNOLOGIES WILL YIELD
项目二:互补基因组技术的变体将会产生
  • 批准号:
    8143191
    8143191
  • 财政年份:
    2011
  • 资助金额:
    $ 158.49万
    $ 158.49万
  • 项目类别:
Program Project: GENE MUTATION AND RESCUE IN HUMAN DIAPHRAGMATIC HERNIA
计划项目:人类膈疝的基因突变与挽救
  • 批准号:
    8291254
    8291254
  • 财政年份:
    2011
  • 资助金额:
    $ 158.49万
    $ 158.49万
  • 项目类别:
Mouse Models Will Elucidate Genetics of CDH and Associated Pulmonary Defects and Identify Clinically Relevant Targets
小鼠模型将阐明 CDH 和相关肺部缺陷的遗传学并确定临床相关目标
  • 批准号:
    10159742
    10159742
  • 财政年份:
    2011
  • 资助金额:
    $ 158.49万
    $ 158.49万
  • 项目类别:
EXPRESSION CORE
表达核心
  • 批准号:
    8143200
    8143200
  • 财政年份:
    2011
  • 资助金额:
    $ 158.49万
    $ 158.49万
  • 项目类别:
Program Project: GENE MUTATION AND RESCUE IN HUMAN DIAPHRAGMATIC HERNIA
计划项目:人类膈疝的基因突变与挽救
  • 批准号:
    8515483
    8515483
  • 财政年份:
    2011
  • 资助金额:
    $ 158.49万
    $ 158.49万
  • 项目类别:
PROJECT I; POLYGENIC CAUSES of ISOLATED and NON-SYNDROMIC CONGENITAL
项目一;
  • 批准号:
    8143184
    8143184
  • 财政年份:
    2011
  • 资助金额:
    $ 158.49万
    $ 158.49万
  • 项目类别:
BIOINFORMATIC CORE
生物信息学核心
  • 批准号:
    8143196
    8143196
  • 财政年份:
    2011
  • 资助金额:
    $ 158.49万
    $ 158.49万
  • 项目类别:
Program Project: GENE MUTATION AND RESCUE IN HUMAN DIAPHRAGMATIC HERNIA
计划项目:人类膈疝的基因突变与挽救
  • 批准号:
    8708173
    8708173
  • 财政年份:
    2011
  • 资助金额:
    $ 158.49万
    $ 158.49万
  • 项目类别:

相似国自然基金

asr基因调控酸诱导的Escherichia coli O157:H7形成VBNC状态的机制研究
  • 批准号:
    32302245
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
Nr5a2f与Nr5a2m基因差异表达在中国大鲵性别分化中的作用与分子机制
  • 批准号:
    32373131
  • 批准年份:
    2023
  • 资助金额:
    50.00 万元
  • 项目类别:
    面上项目
基于材料基因解析的SBS/CR改性沥青遗传变异特征及老化路径追踪
  • 批准号:
    52308455
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
纺锤链霉菌AK308中济南霉素合成基因簇及其途径特异性调控机制研究
  • 批准号:
    32302439
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
基于几丁质酶基因家族的进化分析和功能验证探究哺乳动物食性演化机制
  • 批准号:
    32360119
  • 批准年份:
    2023
  • 资助金额:
    33.00 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Patient oriented research and mentoring program in dermatologic diseases
以患者为中心的皮肤病研究和指导计划
  • 批准号:
    10685455
    10685455
  • 财政年份:
    2023
  • 资助金额:
    $ 158.49万
    $ 158.49万
  • 项目类别:
Pre-clinical Bruker Albira Si PET/SPECT/CT imaging system
临床前 Bruker Albira Si PET/SPECT/CT 成像系统
  • 批准号:
    10633022
    10633022
  • 财政年份:
    2023
  • 资助金额:
    $ 158.49万
    $ 158.49万
  • 项目类别:
Genome Instability Induced Anti-Tumor Immune Responses
基因组不稳定性诱导的抗肿瘤免疫反应
  • 批准号:
    10626281
    10626281
  • 财政年份:
    2023
  • 资助金额:
    $ 158.49万
    $ 158.49万
  • 项目类别:
Core C: Systems Biology Core
核心 C:系统生物学核心
  • 批准号:
    10723638
    10723638
  • 财政年份:
    2023
  • 资助金额:
    $ 158.49万
    $ 158.49万
  • 项目类别:
The Role of Glycosyl Ceramides in Heart Failure and Recovery
糖基神经酰胺在心力衰竭和恢复中的作用
  • 批准号:
    10644874
    10644874
  • 财政年份:
    2023
  • 资助金额:
    $ 158.49万
    $ 158.49万
  • 项目类别: